UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 11, 2004
MYRIAD GENETICS, INC.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
0-26642 |
|
87-0494517 |
|
(State or other |
|
(Commission |
|
(IRS Employer |
|
|
|
|
|
|
|
320
Wakara Way |
||||
|
(Address of principal executive offices) (Zip Code) |
||||
|
|
|
|
|
|
|
Registrant’s telephone number, including area code: (801) 584-3600 |
||||
|
|
|
|
|
|
|
Not Applicable |
||||
|
(Former name or former address, if changed since last report) |
||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 1.01 Entry into a Material Agreement.
On November 11, 2004, the stockholders of Myriad Genetics, Inc. (the “Company”) approved (i) an amendment to the Company’s 2003 Employee, Director and Consultant Stock Option Plan (the “Option Plan”) to increase the number of shares of common stock available for issuance thereunder by 1,400,000 shares and (ii) an amendment to the Company’s Employee Stock Purchase Plan (the “ESPP”) to increase the number of shares of common stock available for issuance thereunder by 200,000 shares. The Option Plan and ESPP, each as amended, are attached hereto as exhibits to this Current Report on Form 8-K and are being filed pursuant to this Item 1.01 as Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K.
ITEM 9.01 Financial Statements and Exhibits.
(c) The following exhibits are filed with this report:
|
Exhibit |
|
Description |
|
|
|
|
|
99.1 |
|
Myriad Genetics, Inc. 2003 Employee, Director and Consultant Stock Option Plan, as amended. |
|
|
|
|
|
99.2 |
|
Myriad Genetics, Inc. Employee Stock Purchase Plan, as amended. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
MYRIAD GENETICS, INC. |
||
|
|
|
||
|
|
|
|
|
|
Date: November 11, 2004 |
By: |
/s/ Peter D. Meldrum |
|
|
|
|
Peter D. Meldrum |
|
|
|
|
President and Chief Executive Officer |
|
3
EXHIBIT INDEX
|
Exhibit |
|
Description |
|
|
|
|
|
99.1 |
|
Myriad Genetics, Inc. 2003 Employee, Directors and Consultant Stock Option Plan, as amended. |
|
|
|
|
|
99.2 |
|
Myriad Genetics, Inc. Employee Stock Purchase Plan, as amended. |
4